- Home
- ESTA vs KTTA Comparison
ESTA vs KTTA Comparison
Compare ESTA & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESTA
- KTTA
- Stock Information
- Founded
- ESTA 2004
- KTTA 2020
- Country
- ESTA Costa Rica
- KTTA United States
- Employees
- ESTA N/A
- KTTA N/A
- Industry
- ESTA Industrial Specialties
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- ESTA Health Care
- KTTA Health Care
- Exchange
- ESTA Nasdaq
- KTTA Nasdaq
- Market Cap
- ESTA 1.3B
- KTTA 5.5M
- IPO Year
- ESTA 2018
- KTTA 2021
- Fundamental
- Price
- ESTA $45.26
- KTTA $0.68
- Analyst Decision
- ESTA Buy
- KTTA
- Analyst Count
- ESTA 6
- KTTA 0
- Target Price
- ESTA $55.00
- KTTA N/A
- AVG Volume (30 Days)
- ESTA 407.1K
- KTTA 142.8K
- Earning Date
- ESTA 08-05-2025
- KTTA 08-12-2025
- Dividend Yield
- ESTA N/A
- KTTA N/A
- EPS Growth
- ESTA N/A
- KTTA N/A
- EPS
- ESTA N/A
- KTTA N/A
- Revenue
- ESTA $170,235,000.00
- KTTA N/A
- Revenue This Year
- ESTA $27.10
- KTTA N/A
- Revenue Next Year
- ESTA $24.55
- KTTA N/A
- P/E Ratio
- ESTA N/A
- KTTA N/A
- Revenue Growth
- ESTA 9.27
- KTTA N/A
- 52 Week Low
- ESTA $26.56
- KTTA $0.67
- 52 Week High
- ESTA $52.41
- KTTA $7.50
- Technical
- Relative Strength Index (RSI)
- ESTA 64.78
- KTTA 32.67
- Support Level
- ESTA $34.34
- KTTA $0.67
- Resistance Level
- ESTA $47.11
- KTTA $0.77
- Average True Range (ATR)
- ESTA 2.42
- KTTA 0.04
- MACD
- ESTA 0.41
- KTTA 0.01
- Stochastic Oscillator
- ESTA 85.47
- KTTA 14.02
About ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).